Riverwood Capital

SAEL Industries IPO Description – SAEL Industries operates as a vertically integrated renewable energy independent power producer (IPP) with a diversified portfolio spanning solar power and agri waste-to-energy (AgWTE). As of September 2025, it has a total contracted and awarded capacity of 5,765.7 MW (8,464.4 MWp), including 5,600.8 MW solar and 164.9 MW AgWTE, spread […]

Prasol Chemicals IPO Description – Prasol Chemicals is a diversified specialty chemicals manufacturer with over 33 years of operating history, focusing on acetone-based and phosphorous-based chemistries, along with customised speciality products. As of July 2025, it offers a portfolio of 150+ specialty chemicals catering to 1,100+ customers across 69 countries, positioning it as a globally

In the landscape of Indian wealth, few names carry the weight of both legacy and transformation quite like Ananya Birla. As a 31-year-old entrepreneur and artist, she has navigated the complex journey of being a sixth-generation scion of one of India’s oldest business families while building a diverse portfolio that is uniquely her own. Let’s

The Indian healthcare sector is witnessing a localised “gold rush” as specialty hospital chains race to tap the primary markets. The latest contender to join the fray is Maxivision Super Specialty Eye Hospitals. According to a Bloomberg report, the Hyderabad-based chain has initiated discussions with investment bankers to structure an IPO that could hit the

The Securities and Exchange Board of India (SEBI) has issued its final observations for the Vishal Nirmiti IPO on 9 April 2026. For those uninitiated with market jargon, the issuance of “observations” by SEBI is effectively the regulatory nod required for a company to launch its public issue. Vishal Nirmiti had filed its Draft Red